Johnson & Johnson’s 1-Shot COVID-19 Vaccine Shows Promise in Early-Stage Trials

Johnson & Johnson’s experimental one-shot Covid-19 vaccine generated a long-lasting immune response in an early safety study, providing a glimpse at how it will perform in the real world as the company inches closer to approaching U.S. regulators for clearance. More than 90% of participants made immune proteins, called neutralizing antibodies, within 29 days after … Read more

Coronavirus Cases Surge in Arizona

Arizona has recorded the highest number of new coronavirus cases per capita in the country. A medical official said the hospital systems are under “immense pressure” to keep up with the amount of Covid-19 patients. View original article Contributor: The Associated Press